Concepedia

Quality-adjusted Survival

Quality-Adjusted Survival is a health economic metric that quantifies the duration of survival weighted by the quality of life during that time, distinguishing it from unadjusted survival measures by incorporating patient-reported or clinically assessed health states.

201

Publications

11K

Citations

1.1K

Authors

571

Institutions

Publications per year

2017–2026

33

Parents

Publications

201

Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation

James V. Freeman, Ruo P. Zhu, Douglas K Owens et al. · Annals of Internal Medicine · 2011 · 427 citations · Full text

, , +17

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

Shimoli Shah, Brian F. Gage · Circulation · 2011 · 337 citations

, , +17

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

Aron Goldhirsch, Richard D. Gelber, R. John Simes et al. · Journal of Clinical Oncology · 1989 · 336 citations

, , +15

Quality-adjusted Survival in the First Year after the Acute Respiratory Distress Syndrome

Derek C. Angus, Amjad A. Musthafa, Gilles Clermont et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 330 citations

, , +16

Improved curve fits to summary survival data: application to economic evaluation of health technologies

Martin Hoyle, William Henley · BMC Medical Research Methodology · 2011 · 309 citations · Full text

, , +17

1–5 of 201

Authors

1.1K

  1. BF
    Bernard F. Cole

    Dartmouth College, United States

    14 publications · 845 citations

    14

    h-index

  2. RD
    Richard D. Gelber

    Dana-Farber Cancer Institute, United States

    12 publications · 1.1K citations

    12

    h-index

  3. AG
    Aron Goldhirsch

    European Institute of Oncology, Italy

    9 publications · 912 citations

    9

    h-index

  4. JW
    Jung‐Der Wang

    National Taiwan University, Taiwan

    7 publications · 324 citations

    7

    h-index

  5. MB
    Marc Botteman

    Pharmerit (United States), United States

    5 publications · 103 citations

    5

    h-index

1–5 of 1.1K

Institutions

571

  1. Dana-Farber Cancer Institute

    Boston, United States

    11 h-index

    28 publications

    878 citations

  2. Harvard University

    Cambridge, United States

    10 h-index

    13 publications

    680 citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    9 h-index

    43 publications

    2.2K citations

  4. Columbia University

    New York, United States

    7 h-index

    30 publications

    2.1K citations

  5. University of Toronto

    Toronto, Canada

    7 h-index

    13 publications

    654 citations

  6. Fox Chase Cancer Center

    Philadelphia, United States

    6 h-index

    18 publications

    1.4K citations

  7. Inserm

    Paris, France

    6 h-index

    17 publications

    369 citations

  8. Stanford University

    Stanford, United States

    6 h-index

    15 publications

    2.8K citations

1–8 of 571

Venues

  1. Journal of Clinical Oncology

    17 publications · 1.6K citations

    16

    h-index

  2. British Journal of Cancer

    BJC · 11 publications · 282 citations

    11

    h-index

  3. PubMed

    Repository · 12 publications · 276 citations

    11

    h-index

  4. Quality of Life Research

    9 publications · 272 citations

    9

    h-index

  5. Value in Health

    8 publications · 212 citations

    8

    h-index

1–5